AAV gene therapy atlas

All 15 AAV gene therapies in the registry, joined to their capsid, transgene, the disease areas of their trials and approvals, routes and shared sponsors. Those that share things sit near each other, so the field's clusters show up on their own. Click a dot to see what it connects to; drag to rearrange or pan; zoom with the + and − buttons, Ctrl-scroll or a pinch.

No confirmed trial (0)Early phase 1 / phase 1 (0)Phase 2 (0)Phase 3 (6)Approved (9)

Stage is the furthest a product has got: an approval anywhere, else the highest phase among its confirmed trials. Disease areas come from those trials' conditions and the approvals' indications, grouped. Products whose capsid no source states have no capsid link.

All AAV gene therapies

ProductCapsidStageTransgenesRouteDisease area
alipogene tiparvovec (Glybera)AAV1Approved, since withdrawnLPL (S447X variant)intramuscularMetabolic and lysosomal
dalnacogene ponparvovec (BBM-H901, XinJiuning)ApprovedF9intravenousBlood
delandistrogene moxeparvovec (Elevidys, SRP-9001)AAVrh74Approvedmicro-dystrophin (DMD)intravenousNeuromuscular
eladocagene exuparvovec (Kebilidi, PTC-AADC, Upstaza)AAV2ApprovedDDCintracerebralBrain and nerves
etranacogene dezaparvovec (Hemgenix)AAV5ApprovedF9 (R338L Padua variant)intravenousBlood
fidanacogene elaparvovec (Beqvez, Durveqtix)AAVRh74varApprovedF9 (R338L Padua variant)intravenousBlood
onasemnogene abeparvovec (Itvisma, OAV-101, Zolgensma)AAV9ApprovedSMN1intravenous, intrathecalNeuromuscular
valoctocogene roxaparvovec (Roctavian)AAV5ApprovedF8 (B-domain deleted)intravenousBlood
voretigene neparvovec (Luxturna)AAV2ApprovedRPE65subretinalEye
4D-150 (4D-150)R100Phase 3intravitrealEye
botaretigene sparoparvovecAAV5Phase 3RPGRsubretinalEye
ixoberogene soroparvovecAAV.7m8Phase 3afliberceptintravitrealEye
laruparetigene zovaparvovec (AGTC-501)Phase 3RPGRsubretinalEye
OCU400 (OCU400)AAV5Phase 3NR2E3Eye
surabgene lomparvovec (ABBV-RGX-314)AAV8Phase 3anti-VEGF Fab (ranibizumab-like)subretinal, suprachoroidalEye